The push to accelerate scientific discovery just got a $34.4M boost, as Biolevate announced its Series A funding round. The company, which develops an AI-native Knowledge Platform for life science organizations, aims to free scientists from repetitive tasks by connecting data, documents, and expertise across the enterprise.
Biolevate's platform standardizes complex scientific workflows, turning unstructured content into structured insight. The Series A round saw participation from a diverse group of investors, including RAISE France, Orange Ventures, MSD Global Health Innovation Fund (MGHIF), Station F, and EQT Ventures.
















